Witt, Stephanie H.
Frank, Josef
Gilles, Maria
Lang, Maren
Treutlein, Jens
Streit, Fabian
Wolf, Isabell A. C.
Peus, Verena
Scharnholz, Barbara
Send, Tabea S.
Heilmann-Heimbach, Stefanie
Sivalingam, Sugirthan
Dukal, Helene
Strohmaier, Jana
Sütterlin, Marc
Arloth, Janine
Laucht, Manfred
Nöthen, Markus M.
Deuschle, Michael
Rietschel, Marcella
Funding for this research was provided by:
EU Era-Net Neuron
EU Era-Net Neuron
Deutsche Forschungsgemeinschaft (FOR2107; RI908/11-1, WI3429/3-1, NO246/10-1)
Bundesministerium für Bildung und Forschung (01ZX1314G, 01ZX1314A)
Dietmar-Hopp Foundation
Article History
Received: 30 November 2017
Accepted: 8 April 2018
First Online: 25 April 2018
Ethics approval and consent to participate
: All data were managed according to the World Medical Association’s Declaration of Helsinki. The study was approved by the Medical Ethics Committee II, Heidelberg University (Medical Faculty Mannheim) and all participating mothers provided written informed consent.
: MD served as PI in phase II and III studies of Johnson & Johnson, Lilly and Roche. He participated in advisory boards of Bristol-Myers Squibb, Lundbeck and Otsuka and received speaker fees of Bristol-Myers Squibb, Janssen, Lundbeck, Mundipharma and Otsuka. The remaining authors declare no competing interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.